English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 121 | Tables: 122 | Pharma & Healthcare
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ 2256 million in 2025 and is anticipated to reach US$ 2018 million by 2032, at a CAGR of -1.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy"s most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
This report delivers a comprehensive overview of the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs. The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Others
by Application
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
1.1 Product Definition
1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type
1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Type: 2025 vs 2032
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application
1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Application: 2025 vs 2032
1.3.2 Acute CINV
1.3.3 Delayed CINV
1.3.4 Breakthrough CINV
1.3.5 Others
1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2021–2032
1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2021–2032
1.4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competition by Manufacturers
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Entry into the Industry
2.8 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Situation and Trends
2.8.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue
2.8.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Scenario by Region
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2021–2032
3.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2021–2026
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2027–2032
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2021–2032
3.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2021–2026
3.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2027–2032
3.4 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.4.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021–2032)
3.4.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.5.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021–2032)
3.5.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.7.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021–2032)
3.7.3 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021–2032)
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021–2026)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2027–2032)
4.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2021–2032)
4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021–2032)
4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021–2026)
4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2027–2032)
4.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021–2032)
5.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021–2026)
5.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2027–2032)
5.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2021–2032)
5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021–2032)
5.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021–2026)
5.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2027–2032)
5.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Heron Therapeutics
6.1.1 Heron Therapeutics Company Information
6.1.2 Heron Therapeutics Description and Business Overview
6.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.1.5 Heron Therapeutics Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Company Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Mundipharma
6.4.1 Mundipharma Company Information
6.4.2 Mundipharma Description and Business Overview
6.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.4.5 Mundipharma Recent Developments/Updates
6.5 Qilu Pharma
6.5.1 Qilu Pharma Company Information
6.5.2 Qilu Pharma Description and Business Overview
6.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.5.5 Qilu Pharma Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Roche
6.8.1 Roche Company Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Company Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 GSK
6.11.1 GSK Company Information
6.11.2 GSK Description and Business Overview
6.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.11.5 GSK Recent Developments/Updates
6.12 Helsinn
6.12.1 Helsinn Company Information
6.12.2 Helsinn Description and Business Overview
6.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.12.5 Helsinn Recent Developments/Updates
6.13 Southwest Pharma
6.13.1 Southwest Pharma Company Information
6.13.2 Southwest Pharma Description and Business Overview
6.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.13.5 Southwest Pharma Recent Developments/Updates
6.14 Haisco
6.14.1 Haisco Company Information
6.14.2 Haisco Description and Business Overview
6.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.14.5 Haisco Recent Developments/Updates
6.15 Sun Pharma
6.15.1 Sun Pharma Company Information
6.15.2 Sun Pharma Description and Business Overview
6.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.15.5 Sun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis
7.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process Analysis
7.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Marketing
7.4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Channels
7.4.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors
7.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customer Analysis
8 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Dynamics
8.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
8.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
8.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
8.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (M Units), 2021–2026
Table 18. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (M Units), 2027–2032
Table 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2021–2026
Table 27. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2027–2032
Table 28. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2021–2026
Table 32. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2027–2032
Table 33. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2021–2026
Table 42. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2027–2032
Table 43. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Type (2021–2026)
Table 51. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Type (2027–2032)
Table 52. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Application (2021–2026)
Table 61. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Application (2027–2032)
Table 62. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Heron Therapeutics Company Information
Table 71. Heron Therapeutics Description and Business Overview
Table 72. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 74. Heron Therapeutics Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 79. Merck Recent Developments/Updates
Table 80. Eisai Company Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 84. Eisai Recent Developments/Updates
Table 85. Mundipharma Company Information
Table 86. Mundipharma Description and Business Overview
Table 87. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 89. Mundipharma Recent Developments/Updates
Table 90. Qilu Pharma Company Information
Table 91. Qilu Pharma Description and Business Overview
Table 92. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 94. Qilu Pharma Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 104. Novartis Recent Developments/Updates
Table 105. Roche Company Information
Table 106. Roche Description and Business Overview
Table 107. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 109. Roche Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 114. Mylan Recent Developments/Updates
Table 115. Baxter Company Information
Table 116. Baxter Description and Business Overview
Table 117. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 119. Baxter Recent Developments/Updates
Table 120. GSK Company Information
Table 121. GSK Description and Business Overview
Table 122. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 124. GSK Recent Developments/Updates
Table 125. Helsinn Company Information
Table 126. Helsinn Description and Business Overview
Table 127. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 129. Helsinn Recent Developments/Updates
Table 130. Southwest Pharma Company Information
Table 131. Southwest Pharma Description and Business Overview
Table 132. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 134. Southwest Pharma Recent Developments/Updates
Table 135. Haisco Company Information
Table 136. Haisco Description and Business Overview
Table 137. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 139. Haisco Recent Developments/Updates
Table 140. Sun Pharma Company Information
Table 141. Sun Pharma Description and Business Overview
Table 142. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 144. Sun Pharma Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 148. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List
Table 149. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Trends
Table 150. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
Table 151. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
Table 152. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Type: 2025 & 2032
Figure 4. 5-HT3 Inhibitors Product Picture
Figure 5. NK1 Inhibitors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Application: 2025 & 2032
Figure 9. Acute CINV
Figure 10. Delayed CINV
Figure 11. Breakthrough CINV
Figure 12. Others
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2021–2032
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Report Years Considered
Figure 18. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players: Market Share by Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in 2025
Figure 21. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021–2032)
Figure 46. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2021–2032)
Figure 56. Global Revenue Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2021–2032)
Figure 57. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application (2021–2032)
Figure 59. Global Revenue Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application (2021–2032)
Figure 60. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2021–2032)
Figure 61. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
